Back to search
Idiopathic Growth Hormone Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Growth Hormone Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Idiopathic Growth Hormone Deficiency trials you may qualify forThis basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS b…
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth…
This is a multi-national trial. The goals of the trial are to study the growth response to LUM-201 administration in children with idiopathic growth hormone def…
The purpose of the study is to measure the functional effects of recombinant GH in skeletal muscle, in addition to growth promotion, in short prepubertal boys w…
This is a multi-national trial. The goals of the trial are to study LUM-201 as a possible treatment for Pediatric Growth Hormone Deficiency (PGHD) and investiga…